Effect of the SARS-CoV-2 pandemic on metabolic control in patients with type 2 diabetes: a 5-year cohort follow-up managed by a dynamic multidisciplinary team in Northeastern Mexico
Authors (first, second and last of 11)
Collection
Diabetes and Covid-19
Since the first reports of Covid-19 in Wuhan, China, research from all around the globe has confirmed the relationship between diabetes, hypertension and cardiovascular disease, and Covid-19 outcomes. The high frequencies of these comorbidities among hospitalized patients and in those with fatal outcome have shown their importance as risk factors for serious outcomes and lethality.
In this Collection we publish research that investigates these relationships as well as treatment and prognosis, physiopathology, epidemiology and any other impact that Covid-19 may have on diabetic patients’ health.
Editors
-
Sergio Vencio
'.'
-
Marcello Bertoluci
'.'
Articles (31 in this collection)
-
-
Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: the prospective Maastricht Intensive Care Covid Cohort
Authors (first, second and last of 11)
-
Prognostic value of the prognostic nutritional index for patients with acute myocardial infarction undergoing percutaneous coronary intervention with variable glucose metabolism statuses: a retrospective cohort study
Authors (first, second and last of 10)
-
Effects of COVID-19 on diabetes care among dutch diabetes outpatients
Authors (first, second and last of 7)
-
Association between inpatient glycemic variability and COVID-19 mortality: a prospective study
Authors (first, second and last of 17)
-
The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
Authors (first, second and last of 10)
-
Correcting calculation and data errors reveals that the original conclusions were incorrect in “The best drug supplement for obesity treatment: a systematic review and network meta-analysis”
Authors (first, second and last of 4)
-
Influence of time factor and albuminuria on characteristics of patients with type 2 diabetes Mellitus before, during and 1 year after COVID-19 recovery
Authors (first, second and last of 4)
-
Geriatric Nutrition Risk Index as a predictor of cardiovascular and all-cause mortality in older Americans with diabetes
Authors (first, second and last of 5)
-
-
Predictive markers for clinical outcomes in a cohort of diabetic patients hospitalized for COVID-19
Authors (first, second and last of 14)
-
Screening of GDM during COVID pandemic in an Italian setting: comparison between IADPSG and WHO ‘99 criteria
Authors (first, second and last of 6)
-
Metabolic syndrome and the immunogenicity of Pfizer–BioNTech vaccine: a cross-sectional study in Japanese healthcare workers
Authors (first, second and last of 6)
-
-
Insulin use in Type 2 diabetic patients: a predictive of mortality in covid‑19 infection
Authors (first, second and last of 9)
-
Quality of care in patients with type 1 diabetes during the COVID-19 pandemic: a cohort study from Southern Brazil
Authors (first, second and last of 6)
-
-
Self-isolation negatively impacts self-management of diabetes during the coronavirus (COVID-19) pandemic
Authors (first, second and last of 5)
-
Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis
Authors (first, second and last of 16)
-
-
Diabetes self-care practices and resilience in the Brazilian COVID-19 pandemic: results of a web survey: DIABETESvid
Authors (first, second and last of 8)
-
Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
Authors (first, second and last of 4)
-
SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy
Authors (first, second and last of 12)
-
Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran
Authors (first, second and last of 10)
-
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Authors (first, second and last of 4)
-
Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus
Authors (first, second and last of 10)
-
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
Authors (first, second and last of 4)
-
Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing
Authors (first, second and last of 11)
-
Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis
Authors (first, second and last of 8)
-
-
Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease
Authors (first, second and last of 15)
